The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, H.
Right arrow Articles by Ildstad, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, H.
Right arrow Articles by Ildstad, S. T.

The Journal of Immunology, Vol 156, Issue 1 380-388, Copyright © 1996 by American Association of Immunologists

ARTICLES

Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice

H Li, CL Kaufman, SS Boggs, PC Johnson, KD Patrene and ST Ildstad
Department of Surgery, University of Pittsburgh, PA 15261, USA.

Evidence in experimental models suggests that many autoimmune diseases can be prevented by transplantation of bone marrow from disease- resistant donors. For potential clinical application, it would be important to avoid the morbidity and mortality associated with lethal conditioning and achieve mixed chimerism using less than complete recipient ablation. We report here for the first time that stable chimerism achieved in NOD mice using a sublethal radiation-based conditioning approach is sufficient to prevent beta-cell destruction and abrogate insulitis in prediabetic NOD mice. The percentage of NOD mouse recipients (8 wk of age) that engrafted with donor bone marrow correlated with the dose of irradiation and number of bone marrow cells transplanted. Engraftment of B10.BR bone marrow occurred in > or = 94% of animals receiving > or = 750 cGy of total body irradiation before bone marrow transplantation and > or = 30 x 10(6) bone marrow cells, while reproducible engraftment did not occur at radiation doses of less than 700 cGy and cellular doses of less than 30 x 10(6) bone marrow cells. All chimeric animals remained free of diabetes (n = 38) for 10 mo following bone marrow transplantation. Moreover, in all animals examined, no insulitis was present from 12 to 36 wk following reconstitution. In striking contrast, 61% (22 of 36) of NOD recipients that were conditioned but did not receive bone marrow developed acute diabetes by 12 mo. Insulitis was present in all remaining animals. These results suggest that allogeneic chimerism achieved using a sublethal conditioning approach can prevent the onset of diabetes and even reverse preexisting insulitis in NOD mice.


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
X. Huang, D. J. Moore, R. J. Ketchum, C. S. Nunemaker, B. Kovatchev, A. L. McCall, and K. L. Brayman
Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation
Endocr. Rev., August 1, 2008; 29(5): 603 - 630.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. F. N. Chan, H. Razavy, B. Luo, A. M. J. Shapiro, and C. C. Anderson
Development of Either Split Tolerance or Robust Tolerance along with Humoral Tolerance to Donor and Third-Party Alloantigens in Nonmyeloablative Mixed Chimeras
J. Immunol., April 15, 2008; 180(8): 5177 - 5186.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
G.-J. Wang, X.-K. Li, K. Sakai, and Lu Cai
Low-dose radiation and its clinical implications: diabetes
Human and Experimental Toxicology, February 1, 2008; 27(2): 135 - 142.
[Abstract] [PDF]

Home page
 Stem CellsHome page
L. Verda, D. A. Kim, S. Ikehara, L. Statkute, D. Bronesky, Y. Petrenko, Y. Oyama, X. He, C. Link, N. N. Vahanian, et al.
Hematopoietic Mixed Chimerism Derived from Allogeneic Embryonic Stem Cells Prevents Autoimmune Diabetes Mellitus in NOD Mice
Stem Cells, February 1, 2008; 26(2): 381 - 386.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Tian, M. J. I. Ansari, J. Paez-Cortez, J. Bagley, J. Godwin, M. Donnarumma, M. H. Sayegh, and J. Iacomini
Induction of Robust Diabetes Resistance and Prevention of Recurrent Type 1 Diabetes Following Islet Transplantation by Gene Therapy
J. Immunol., November 15, 2007; 179(10): 6762 - 6769.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Zhang, I. Todorov, C.-L. Lin, M. Atkinson, F. Kandeel, S. Forman, and D. Zeng
Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD mice
PNAS, February 13, 2007; 104(7): 2337 - 2342.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y.-G. Chen, P. A. Silveira, M. A. Osborne, H. D. Chapman, and D. V. Serreze
Cellular Expression Requirements for Inhibition of Type 1 Diabetes by a Dominantly Protective Major Histocompatibility Complex Haplotype
Diabetes, February 1, 2007; 56(2): 424 - 430.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. V. Serreze, M. A. Osborne, Y.-G. Chen, H. D. Chapman, T. Pearson, M. A. Brehm, and D. L. Greiner
Partial versus Full Allogeneic Hemopoietic Chimerization Is a Preferential Means to Inhibit Type 1 Diabetes as the Latter Induces Generalized Immunosuppression
J. Immunol., November 15, 2006; 177(10): 6675 - 6684.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. S. Narang and R. I. Mahato
Biological and biomaterial approaches for improved islet transplantation.
Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Bottino and M. Trucco
Multifaceted Therapeutic Approaches for a Multigenic Disease
Diabetes, December 1, 2005; 54(suppl_2): S79 - S86.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Flierman, H. J. Witteveen, E. I. H. van der Voort, T. W. J. Huizinga, R. R. P. de Vries, W. E. Fibbe, R. E. M. Toes, and J. M. van Laar
Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation
Blood, April 1, 2005; 105(7): 2991 - 2994.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. T. Ildstad, P. M. Chilton, H. Xu, M. A. Domenick, and M. B. Ray
Preconditioning of NOD mice with anti-CD8 mAb and costimulatory blockade enhances chimerism and tolerance and prevents diabetes, while depletion of {alpha}{beta}-TCR+ and CD4+ cells negates the effect
Blood, March 15, 2005; 105(6): 2577 - 2584.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Liang, T. Huang, C. Zhang, I. Todorov, M. Atkinson, F. Kandeel, S. Forman, and D. Zeng
Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb
Blood, March 1, 2005; 105(5): 2180 - 2188.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. M. Chilton, F. Rezzoug, M. Z. Ratajczak, I. Fugier-Vivier, J. Ratajczak, M. Kucia, Y. Huang, M. K. Tanner, and S. T. Ildstad
Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients
Blood, March 1, 2005; 105(5): 2189 - 2197.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. M. Chilton, F. Rezzoug, I. Fugier-Vivier, L. A. Weeter, H. Xu, Y. Huang, M. B. Ray, and S. T. Ildstad
Flt3-Ligand Treatment Prevents Diabetes in NOD Mice
Diabetes, August 1, 2004; 53(8): 1995 - 2002.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. Nikolic, Y. Takeuchi, I. Leykin, Y. Fudaba, R. N. Smith, and M. Sykes
Mixed Hematopoietic Chimerism Allows Cure of Autoimmune Diabetes Through Allogeneic Tolerance and Reversal of Autoimmunity
Diabetes, February 1, 2004; 53(2): 376 - 383.
[Abstract] [Full Text]

Home page
 DiabetesHome page
C. Ricordi
Lilly Lecture 2002: Islet Transplantation: A Brave New World
Diabetes, July 1, 2003; 52(7): 1595 - 1603.
[Full Text] [PDF]

Home page
 Stem CellsHome page
T. D. Zorina, V. M. Subbotin, S. Bertera, A. M. Alexander, C. Haluszczak, B. Gambrell, R. Bottino, A. J. Styche, and M. Trucco
Recovery of the Endogenous {beta} Cell Function in the NOD Model of Autoimmune Diabetes
Stem Cells, July 1, 2003; 21(4): 377 - 388.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. F. Beilhack, Y. C. Scheffold, I. L. Weissman, C. Taylor, L. Jerabek, M. J. Burge, M. A. Masek, and J. A. Shizuru
Purified Allogeneic Hematopoietic Stem Cell Transplantation Blocks Diabetes Pathogenesis in NOD Mice
Diabetes, January 1, 2003; 52(1): 59 - 68.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Yamamoto, B. Wang, S. Fukuhara, S. Ikehara, and R. A. Good
Mixed peripheral blood stem cell transplantation for autoimmune disease in BXSB/MpJ mice
Blood, August 13, 2002; 100(5): 1886 - 1893.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Xu, B. G. Exner, D. E. Cramer, M. K. Tanner, Y. M. Mueller, and S. T. Ildstad
CD8+, {alpha}{beta}-TCR+, and {gamma}{delta}-TCR+ Cells in the Recipient Hematopoietic Environment Mediate Resistance to Engraftment of Allogeneic Donor Bone Marrow
J. Immunol., February 15, 2002; 168(4): 1636 - 1643.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. K. Burt, S. Slavin, W. H. Burns, and A. M. Marmont
Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?
Blood, February 1, 2002; 99(3): 768 - 784.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A M Marmont
Lupus: tinkering with haematopoietic stem cells
Lupus, November 1, 2001; 10(11): 769 - 774.
[PDF]

Home page
 J. Leukoc. Biol.Home page
N. Ishimori, K. Iwabuchi, S. Fujii, K. Watano, C. Iwabuchi, M. Ato, H. Chiba, S. Tanaka, A. Kitabatake, and K. Onoé
Mixed allogeneic chimerism with wild-type strains ameliorates atherosclerosis in apolipoprotein E-deficient mice
J. Leukoc. Biol., May 1, 2001; 69(5): 732 - 740.
[Abstract] [Full Text]

Home page
 BloodHome page
P. J. Quesenberry, S. Zhong, H. Wang, and M. Stewart
Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice
Blood, January 15, 2001; 97(2): 557 - 564.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
H. Hayashi, J. Toki, L. Zhexiong, K. Sugiura, K. Inoue, and S. Ikehara
Long-Term (>1 year) Analyses of Chimerism and Tolerance in Mixed Allogeneic Chimeric Mice Using Normal Mouse Combinations
Stem Cells, July 1, 2000; 18(4): 273 - 280.
[Abstract] [Full Text]

Home page
 BloodHome page
E. Seung, N. Iwakoshi, B. A. Woda, T. G. Markees, J. P. Mordes, A. A. Rossini, and D. L. Greiner
Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice
Blood, March 15, 2000; 95(6): 2175 - 2182.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Storb, C. Yu, T. Barnett, J. L. Wagner, H. J. Deeg, R. A. Nash, H.-P. Kiem, P. McSweeney, K. Seidel, G. Georges, et al.
Stable Mixed Hematopoietic Chimerism in Dog Leukocyte Antigen-Identical Littermate Dogs Given Lymph Node Irradiation Before and Pharmacologic Immunosuppression After Marrow Transplantation
Blood, August 1, 1999; 94(3): 1131 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A M Marmont
Intense immunosuppression and stem cell transplantation or rescue for severe systemic lupus erythematosus
Lupus, May 1, 1999; 8(4): 256 - 257.
[PDF]

Home page
 Stem CellsHome page
D.W. van Bekkum
Autologous Stem Cell Transplantation for Treatment of Autoimmune Diseases
Stem Cells, May 1, 1999; 17(3): 172 - 178.
[Full Text]

Home page
 J. Immunol.Home page
G. A. Hanley, J. Schiffenbauer, and E. S. Sobel
Resistance to HgCl2-Induced Autoimmunity in Haplotype-Heterozygous Mice Is an Intrinsic Property of B Cells
J. Immunol., August 15, 1998; 161(4): 1778 - 1785.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Storb, C. Yu, J. L. Wagner, H. J. Deeg, R. A. Nash, H.-P. Kiem, W. Leisenring, and H. Shulman
Stable Mixed Hematopoietic Chimerism in DLA-Identical Littermate Dogs Given Sublethal Total Body Irradiation Before and Pharmacological Immunosuppression After Marrow Transplantation
Blood, April 15, 1997; 89(8): 3048 - 3054.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.